23 studies found for:    Open Studies | "Hemorrhagic Fevers, Viral"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Hemorrhagic Fevers, Viral" (23 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Not yet recruiting Phase 2a Immunogenicity Study of Hantaan/Puumala Virus DNA Vaccine for Prevention of Hemorrhagic Fever
Condition: Hemorrhagic Fever With Renal Syndrome
Interventions: Biological: HTNV/PUUV DNA vaccine;   Biological: Placebo
2 Recruiting Immunologic Mechanisms of Immune Interference and/or Cross-Neutralizing Immunity After CYD Tetravalent Dengue Vaccine
Conditions: Dengue;   Dengue Fever;   Dengue Hemorrhagic Fever
Interventions: Biological: CYD Dengue Vaccine;   Biological: CYD Dengue and Japanese Encephalitis Vaccines;   Biological: Japanese Encephalitis and CYD Dengue Vaccines
3 Recruiting Chinese and Western Medicine Treatment of Fever Associated With Bleeding Symptoms
Conditions: Viral Haemorrhagic Fever;   Dengue Fever
Interventions: Drug: Western Medicine;   Drug: TCM and Western Medicine
4 Recruiting Safety, Tolerability and Pharmacokinetic First in Human (FIH) Study for Intravenous (IV) TKM-100802
Condition: Ebola Virus Infection
Interventions: Drug: TKM-100802 for Injection;   Drug: Placebo
5 Recruiting Adult Dengue Platelet Study
Condition: Dengue Fever
Interventions: Procedure: Platelet transfusion;   Other: Supportive care
6 Recruiting International Research Consortium on Dengue Risk Assessment, Management, and Surveillance
Condition: Dengue Fever
Intervention: Other: Observation
7 Recruiting Laboratory Diagnosis and Prognosis of Severe Dengue
Condition: Dengue Fever
Intervention:
8 Not yet recruiting Ability of Bedside Ultrasound to Predict Progression of Severity of Disease in Dengue Fever
Conditions: Dengue;   Disease Progression
Intervention: Other: diagnostic bedside ultrasound
9 Not yet recruiting Study to Determine the Safety, Tolerability and Pharmacokinetics of UV-4B Solution Administered Orally in Healthy Subjects
Condition: Dengue Fever
Interventions: Drug: UV-4B;   Drug: Placebo
10 Not yet recruiting Efficacy and Safety of Ivermectin Against Dengue Infection
Condition: Dengue Fever
Interventions: Drug: 2 days Ivermectin;   Drug: 3 days Ivermectin;   Drug: Placebo
11 Not yet recruiting Safety and Immunogenicity of Three Formulations of Takeda's Tetravalent Dengue Vaccine Candidate (TDV)
Condition: Dengue Fever
Interventions: Drug: Study Drug 1;   Drug: TDV Study Drug 2;   Drug: Study Drug 3;   Drug: TDV Placebo
12 Recruiting Investigation of the Immuno-regulation and Viral Hepatitis Among Patients With or After Dengue Fever Infection
Condition: Dengue Fever
Intervention: Genetic: CLEC5A
13 Recruiting Pilot Survey of Dengue Fever in Solomon Islands
Condition: Arbovirus Infections
Intervention:
14 Unknown  West Indies-French Guiana Dengue Study
Conditions: Fever;   Dengue
Interventions: Other: biological sample collection;   Other: quality of life questionnaire EuroQol®
15 Unknown  Prospective Study of Infant Dengue
Condition: Dengue
Intervention:
16 Recruiting Evaluating the Safety and Immune Response to Two Doses of a Dengue Virus Vaccine Administered 12 Months Apart
Condition: Dengue
Interventions: Biological: TV003 Vaccine;   Biological: Placebo Vaccine
17 Recruiting Phase II Trial to Evaluate Safety and Immunogenicity of a Dengue 1,2,3,4 (Attenuated) Vaccine
Condition: Dengue
Interventions: Biological: dengue lyophilized vaccine;   Biological: dengue liquid vaccine;   Other: Placebo
18 Not yet recruiting An Epidemiological Surveillance Study to Evaluate the Incidence of Dengue in Brazil
Condition: Dengue
Interventions: Procedure: Blood sample collection;   Other: Data collection
19 Unknown  Dengue Seroprevalence Study in Blood Donors in the French West Indies
Conditions: Blood Donors;   Dengue
Intervention: Other: Biological sample collection
20 Recruiting Evaluating the Safety and Effectiveness of a Dengue Virus Vaccine in Healthy Adults
Condition: Dengue
Interventions: Biological: TetraVax-DV-TV003;   Biological: rDEN2∆30-7169;   Biological: Placebo

Previous Page Studies Shown (1-20) Next Page (21-23) Show next page of results
Indicates status has not been verified in more than two years